Q2 2022 Torrent Pharmaceuticals Ltd Earnings Call Transcript
Gentlemen, good day, and welcome to the Torrent Pharma Limited Q2 FY '22 Earnings Conference Call. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Sudhir Menon. Thank you, and over to you, sir.
Thank you. Good evening, everyone, and welcome to quarter 2 FY '22 Earnings Call of Torrent Pharma. Quarter 2 was driven by a strong momentum in the branded generic market. In terms of financial performance, during the quarter, the revenues were INR 2,137 crores, up by 6% on Y-o-Y basis. EBITDA was INR 711 crores, up by 11% on Y-o-Y basis. The profit before tax was at INR 472 crores, which was up by 23%. Net profit after taxes were at INR 316 crores, up by 2%.
Aman, over to you for taking us through the India business performance.
Thanks, Sudhir. India revenues at INR 1,087 crores grew by 13% on a year-on-year basis.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |